Luye Pharma Group Ltd. (LYPHF) Financials

LYPHF Assets vs Liabilities
DateAssetsLiabilities
June 30, 2025 4.5 billion 2.2 billion
Dec. 31, 2024 4.1 billion 1.9 billion
June 30, 2024 3.7 billion 1.8 billion
March 31, 2024 3.8 billion 1.8 billion

LYPHF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2025 249.1 million 926424
Dec. 31, 2024 -157.0 million 1.5 million
June 30, 2024 -54.3 million 1.4 million
March 31, 2024 -27.3 million 712614

LYPHF Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2025 43.7 million
Dec. 31, 2024 61.8 million
June 30, 2024 53.4 million
March 31, 2024 26.9 million

LYPHF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2025 1.2 billion 434.4 million 8.0 million
Dec. 31, 2024 890.9 million 369.1 million 8.5 million
June 30, 2024 891.7 million 376.3 million 9.4 million
March 31, 2024 897.3 million - -

LYPHF Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2025 525.1 million
Dec. 31, 2024 515.3 million
June 30, 2024 517.7 million
March 31, 2024 520.9 million

LYPHF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2025 - 27.0 million 186.2 million 142.2 million
Dec. 31, 2024 234.1 million 29.8 million 172.4 million 132.3 million
June 30, 2024 13.7 million 38.7 million 156.9 million 117.1 million
March 31, 2024 - 19.4 million 20.0 million 58.9 million

LYPHF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2025 444.0 million 142.9 million
Dec. 31, 2024 409.2 million 139.9 million
June 30, 2024 423.1 million 137.1 million
March 31, 2024 212.9 million 69.0 million

LYPHF

Price: $0.27

52 week price:
0.20
0.40

Earnings Per Share: 0.02 USD

P/E Ratio: 18.88

Exchange: PNK

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 815.3 million

Links: